|
Novel C3aR
agonists and antagonists for inhibiting pro-inflammatory activities of the human
complement system targeting C3aR
Princeton Docket # 12-2813
Novel agonists to C3aR have been designed using a de novo design
framework. The best predicted peptides were experimentally validated using a rat
basophilic leukemia cell degranulation assay and...
Published: 3/30/2022
|
Inventor(s): Christodoulos Floudas (DECEASED) See Fotini P. Baba, Meghan Bellows Peterson, Dimitrios Morikis, Peter Monk, Trent Woodruff
Keywords(s):
Category(s): Biotechnology/Pharmaceuticals
|